(12-214) Medication Use Evaluation of 3-hydroxy-3-methylglutaryl Coenzyme-A Reductase Inhibitors in the Treatment of Hyperlipidemia and Prevention of Atherosclerotic Cardiovascular Disease Among Adults with Cystic Fibrosis
Wednesday, December 7, 2022
2:00 PM – 3:00 PM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Drug Information/Drug Use Evaluation
Co-Author(s): Kimberly McBennett, Leesa Prunty
Primary Author(s)
Isaiah P. Bailey, PharmD, RPh
PGY1 Specialty Pharmacy Resident University Hospitals Specialty Pharmacy Services, Ohio
